Leonteq Securities’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-50,000
Closed -$231K – 1350
2026
Q2
$231K Hold
50,000
– – 0.01% 545
2026
Q1
$144K Sell
50,000
-50,000
-50% -$107K 0.01% 661
2025
Q4
$161K Hold
100,000
– – ﹤0.01% 708
2025
Q3
$168K Hold
100,000
– – 0.01% 631
2025
Q2
$121K Buy
100,000
+60,000
+150% +$87K ﹤0.01% 682
2025
Q1
$50.8K Sell
40,000
-14,220
-26% -$37.1K ﹤0.01% 827
2024
Q4
$176K Hold
54,220
– – 0.01% 571
2024
Q3
$178K Hold
54,220
– – 0.01% 512
2024
Q2
$230K Buy
+54,220
New +$528K 0.02% 452
2021
Q1
– Sell
-500
Closed -$11.4K – 1057
2020
Q4
$11.4K Buy
+500
New +$11.5K ﹤0.01% 907

Other funds holding MGNX

Leonteq Securities's MGNX Position: Q3 2026 in Review

Leonteq Securities sold out of MacroGenics (MGNX) in Q3 2026, closing a stake of 50,000 shares — an estimated $231K sold.

Leonteq Securities first reported a position in MGNX in Q4 2020 and held it in 10 quarters. The position peaked at $231K in Q2 2026. 131 funds tracked by Wall St. Rank hold MGNX as of Q3 2026.

  • Leonteq Securities reported no remaining MacroGenics position as of Q3 2026 after selling out during the quarter.
  • Leonteq Securities sold 50,000 MacroGenics shares in Q3 2026, an estimated $231K.
  • Leonteq Securities first reported a position in MacroGenics in Q4 2020 and held it in 10 quarters.
  • Leonteq Securities's MacroGenics position peaked at $231K in Q2 2026.
  • 131 funds tracked by Wall St. Rank held MacroGenics as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.